Literature DB >> 17576861

Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome.

Qiuming Gong1, Li Zhang, G Michael Vincent, Benjamin D Horne, Zhengfeng Zhou.   

Abstract

BACKGROUND: Long-QT syndrome type 2 (LQT2) is caused by mutations in the human ether-a-go-go-related gene (hERG). More than 30% of the LQT2 mutations result in premature termination codons. Degradation of premature termination codon-containing mRNA transcripts by nonsense-mediated mRNA decay is increasingly recognized as a mechanism for reducing mRNA levels in a variety of human diseases. However, the role of nonsense-mediated mRNA decay in LQT2 mutations has not been explored. METHODS AND
RESULTS: We examined the expression of hERG mRNA in lymphocytes from patients carrying the R1014X mutation using a technique of allele-specific transcript quantification. The R1014X mutation led to a reduced level of mutant mRNA compared with that of the wild-type allele. The decrease in mutant mRNA also was observed in the LQT2 nonsense mutations W1001X and R1014X using hERG minigenes expressed in HEK293 cells or neonatal rat ventricular myocytes. Treatment with the protein synthesis inhibitor cycloheximide or RNA interference-mediated knockdown of the Upf1 protein resulted in the restoration of mutant mRNA to levels comparable to that of the wild-type minigene, suggesting that hERG nonsense mutations are subject to nonsense-mediated mRNA decay.
CONCLUSIONS: These results indicate that LQT2 nonsense mutations cause a decrease in mutant mRNA levels by nonsense-mediated mRNA decay rather than production of truncated proteins. Our findings suggest that the degradation of hERG mutant mRNA by nonsense-mediated mRNA decay is an important mechanism in LQT2 patients with nonsense or frameshift mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576861      PMCID: PMC2376840          DOI: 10.1161/CIRCULATIONAHA.107.708818

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

1.  Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios.

Authors:  H Uejima; M P Lee; H Cui; A P Feinberg
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

2.  Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes.

Authors:  L Zhang; K W Timothy; G M Vincent; M H Lehmann; J Fox; L C Giuli; J Shen; I Splawski; S G Priori; S J Compton; F Yanowitz; J Benhorin; A J Moss; P J Schwartz; J L Robinson; Q Wang; W Zareba; M T Keating; J A Towbin; C Napolitano; A Medina
Journal:  Circulation       Date:  2000-12-05       Impact factor: 29.690

3.  Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon.

Authors:  J Lykke-Andersen; M D Shu; J A Steitz
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

4.  Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.

Authors:  Qiuming Gong; David R Keeney; Maurizio Molinari; Zhengfeng Zhou
Journal:  J Biol Chem       Date:  2005-03-10       Impact factor: 5.157

5.  Analysis of the human KCNH2(HERG) gene: identification and characterization of a novel mutation Y667X associated with long QT syndrome and a non-pathological 9 bp insertion.

Authors:  A Paulussen; P Yang; M Pangalos; P Verhasselt; R Marrannes; C Verfaille; I Vandenberk; R Crabbe; F Konings; W Luyten; M Armstrong
Journal:  Hum Mutat       Date:  2000-05       Impact factor: 4.878

6.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

7.  Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.

Authors:  Arthur J Moss; Wojciech Zareba; Elizabeth S Kaufman; Eric Gartman; Derick R Peterson; Jesaia Benhorin; Jeffrey A Towbin; Mark T Keating; Silvia G Priori; Peter J Schwartz; G Michael Vincent; Jennifer L Robinson; Mark L Andrews; Changyong Feng; W Jackson Hall; Aharon Medina; Li Zhang; Zhiqing Wang
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

8.  Defective human Ether-à-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus.

Authors:  Sabina Kupershmidt; Tao Yang; Siprachanh Chanthaphaychith; Zhiqing Wang; Jeffrey A Towbin; Dan M Roden
Journal:  J Biol Chem       Date:  2002-05-20       Impact factor: 5.157

9.  Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome.

Authors:  Qiuming Gong; David R Keeney; Jeffrey C Robinson; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2004-12       Impact factor: 5.000

10.  A GFP-based reporter system to monitor nonsense-mediated mRNA decay.

Authors:  Alexandra Paillusson; Nadine Hirschi; Claudio Vallan; Claus M Azzalin; Oliver Mühlemann
Journal:  Nucleic Acids Res       Date:  2005-03-30       Impact factor: 16.971

View more
  49 in total

1.  Alternative splicing and polyadenylation contribute to the generation of hERG1 C-terminal isoforms.

Authors:  Qiuming Gong; Matthew R Stump; A Russell Dunn; Vivianne Deng; Zhengfeng Zhou
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

Review 2.  HERG1 channelopathies.

Authors:  Michael C Sanguinetti
Journal:  Pflugers Arch       Date:  2009-11-22       Impact factor: 3.657

3.  Multiple splicing defects caused by hERG splice site mutation 2592+1G>A associated with long QT syndrome.

Authors:  Matthew R Stump; Qiuming Gong; Zhengfeng Zhou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

Review 4.  hERG quality control and the long QT syndrome.

Authors:  Brian Foo; Brittany Williamson; Jason C Young; Gergely Lukacs; Alvin Shrier
Journal:  J Physiol       Date:  2016-02-09       Impact factor: 5.182

5.  Gasping for answers. Focus on "Calpain activation by ROS mediates human ether-a-go-go-related gene protein degradation by intermittent hypoxia".

Authors:  Ramon J Ayon; Haiyang Tang; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2016-02-03       Impact factor: 4.249

6.  LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation.

Authors:  Matthew R Stump; Qiuming Gong; Zhengfeng Zhou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

7.  Inhibition of nonsense-mediated mRNA decay by antisense morpholino oligonucleotides restores functional expression of hERG nonsense and frameshift mutations in long-QT syndrome.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

Review 8.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Authors:  Lucie Carrier; Saskia Schlossarek; Monte S Willis; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

9.  Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations.

Authors:  Matthew D Perry; Chai Ann Ng; Kevin Phan; Erikka David; Kieran Steer; Mark J Hunter; Stefan A Mann; Mohammad Imtiaz; Adam P Hill; Ying Ke; Jamie I Vandenberg
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

10.  Clinical and genetic analysis of long QT syndrome in children from six families in Saudi Arabia: are they different?

Authors:  Zahurul A Bhuiyan; Safar Al-Shahrani; Ayman S Al-Khadra; Saleh Al-Ghamdi; Khalaf Al-Khalaf; Marcel M A M Mannens; Arthur A M Wilde; Tarek S Momenah
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.